Nuveen Asset Management’s Spero Therapeutics SPRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-60,598
| Closed | -$516K | – | 3384 |
|
|
2022
Q1 | $516K | Hold |
60,598
| – | – | ﹤0.01% | 3007 |
|
|
2021
Q4 | $780K | Sell |
60,598
-10,523
| -15% | -$135K | ﹤0.01% | 2941 |
|
|
2021
Q3 | $1.36M | Buy |
71,121
+7,079
| +11% | +$136K | ﹤0.01% | 2849 |
|
|
2021
Q2 | $894K | Sell |
64,042
-308
| -0.5% | -$4.3K | ﹤0.01% | 3049 |
|
|
2021
Q1 | $948K | Sell |
64,350
-18,596
| -22% | -$274K | ﹤0.01% | 2901 |
|
|
2020
Q4 | $1.61M | Buy |
82,946
+31,982
| +63% | +$620K | ﹤0.01% | 2616 |
|
|
2020
Q3 | $569K | Sell |
50,964
-13,599
| -21% | -$152K | ﹤0.01% | 2910 |
|
|
2020
Q2 | $873K | Buy |
64,563
+20,510
| +47% | +$277K | ﹤0.01% | 2672 |
|
|
2020
Q1 | $356K | Buy |
44,053
+5,656
| +15% | +$45.7K | ﹤0.01% | 2881 |
|
|
2019
Q4 | $369K | Sell |
38,397
-5,495
| -13% | -$52.8K | ﹤0.01% | 2963 |
|
|
2019
Q3 | $465K | Buy |
43,892
+6,416
| +17% | +$68K | ﹤0.01% | 2969 |
|
|
2019
Q2 | $431K | Buy |
+37,476
| New | +$431K | ﹤0.01% | 3041 |
|